The "Dry Eye Disease - Pipeline Insight, 2025" report has been added to ResearchAndMarkets.com's offering.An in-depth report providing extensive information on the current therapeutic landscape for ...

Fast track was first introduced by FDA to expedite development and review of drugs to treat serious conditions lacking any FDA-approved drug,” commented Gary S. Jacob, Ph.D., Chief Executive Officer ...

encompassing data demonstrating improvement that may occur within minutes of drug administration in symptoms and three different objective signs." "In contrast to currently available dry eye ...

Treatments for dry eye disease, neuroendocrine tumors, chronic spontaneous urticaria, Barth syndrome, and migraine are under review.

The pipeline for dry eye disease drugs is beginning to heat up, with two biotechs announcing key developments, aiming to disrupt a market led by Allergan and Novartis. Novartis paid Takeda $3.4 ...

This means that your eye care provider already has used other options to treat dry eye, such as ointments and prescription medications. Punctal plugs are not a cure for dry eye, but they can ...

Urcosmid is a lipid conjugated chemerin peptide agonist of the ChemR23 G-protein coupled receptor, typically found on immune ...

Medically reviewed by Alex Yampolsky, PharmD Diflucan (fluconazole) is an antifungal drug that treats various fungal ...

Reproxalap, a first-in-class small-molecule modulator of reactive aldehyde species (RASP), is under review for the treatment of the signs and symptoms of dry eye disease. It works by covalently ...

To protect your eye health and support your vision, these are 10 simple things you can do every day for your eyes.

Aldeyra's reproxalap faced an FDA setback but showed positive trial results, leading to a resubmitted NDA. Click here to find ...